Join Today and Give Back

New Clues to How the Tumor Microenvironment Impacts Pancreatic Cancer

August 22, 2022


Read time:

<5 mins
Gloved Hands Pipette Vial Specimen
Presented by Health Lab

Researchers from the U-M Rogel Cancer Center are interested in a new form of pancreatic cancer treatment that disrupts cell “crosstalk” and resulting tumor growth. A new study discusses recent findings on mitochondrial metabolism, a key driver of pancreatic cancer. The authors discuss their research and the potential for new treatments.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.